BTSG on Nasdaq
BrightSpring Health Services, Inc.
$62.45 down 0.90 (1.42%)Price as of Oct 15, 2026 at 19:45 UTC
Last updated Oct 16, 2026.
Overview
Compare with Option Care Health, Inc., AdaptHealth Corp. or Chemed Corporation, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
11.8%Gross margin4
2.3%Operating margin4
1.5%Net margin4
28.2%Revenue growth, 20254
10.2%Return on equity4
1.31×Debt to equity4
$394.7MFree cash flow4
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Medicare D brought in 32% of the revenue BrightSpring Health Services, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Medicare D | $2.0B | $3.2B | $4.1B |
| Commercial Insurance | $1.8B | $2.5B | $3.3B |
| Medicare C | $1.5B | $1.7B | $2.4B |
| Medicaid | $979.1M | $1.2B | $1.5B |
| Medicare A | $958.6M | $999.6M | $1.1B |
| Private and Other | $378.0M | $415.1M | $424.1M |
| Medicare B | $82.8M | $95.9M | $82.8M |
Business segments
Pharmacy Solutions brought in 89% of the revenue BrightSpring Health Services, Inc. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Pharmacy Solutions | $6.5B | $8.8B | $11.4B |
| Provider Services | $1.2B | $1.3B | $1.5B |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Selling, general and admin9¢$1.2B
- Other costs88¢$11.3B
- Interest1¢$157.3M
- Income tax0¢$33.1M
- Profit1¢$190.7M
Out of $12.9B in revenue.4
Where each dollar of operating cash went, fiscal 2025
- Capital spending19¢$95.5M
- Share buybacks9¢$43.2M
- Kept or used elsewhere72¢$351.5M
Out of $490.2M of cash from operations.4
Financial statements
Every line of the income statement in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total revenues | $12.9B | $10.1B | $7.7B |
| Cost of goods | $10.5B | $8.0B | $5.8B |
| Cost of services | $885.4M | $797.3M | $711.3M |
| Gross profit | $1.5B | $1.3B | $1.1B |
| Selling, general, and administrative expenses | $1.2B | $1.2B | $1.1B |
| Operating income | $295.3M | $108.0M | $58.1M |
| Loss on extinguishment of debt | $12.7M | ||
| Interest expense, net | $157.3M | $190.5M | $271.9M |
| Income (loss) from continuing operations before income taxes | $137.9M | -$95.3M | -$213.8M |
| Income tax expense (benefit) | $33.1M | -$26.4M | -$31.5M |
| Net income (loss) from continuing operations | $104.8M | -$68.9M | -$182.3M |
| Income from discontinued operations, net of income taxes | $84.3M | $48.4M | $25.4M |
| Net income (loss) | $189.1M | -$20.5M | -$156.8M |
| Net loss attributable to noncontrolling interests included in continuing operations | -$1.6M | -$2.5M | -$2.2M |
| Net income (loss) attributable to BrightSpring Health Services, Inc. and subsidiaries | $190.7M | -$18.1M | -$154.6M |
| Continuing operations | $1 | -$0 | -$2 |
| Discontinued operations | $0 | $0 | $0 |
| Net income (loss) per share | $0.94 | -$0.09 | -$1.31 |
| Continuing operations | $0 | -$0 | -$2 |
| Discontinued operations | $0 | $0 | $0 |
| Net income (loss) per share | $0.87 | -$0.09 | -$1.31 |
| Basic | 202.6M shares | 193.0M shares | 117.9M shares |
| Diluted | 219.8M shares | 193.0M shares | 117.9M shares |
Every line of the balance sheet in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $88.4M | $61.0M | |
| Accounts receivable, net of allowance for credit losses | $989.7M | $902.8M | |
| Inventories | $815.2M | $636.6M | |
| Prepaid expenses and other current assets | $118.6M | $161.3M | |
| Total current assets | $2.9B | $1.9B | |
| Property and equipment, net of accumulated depreciation of $404,878 and $339,892 at December 31, 2025 and 2024, respectively | $204.7M | $180.6M | |
| Goodwill | $2.5B | $2.4B | $2.3B |
| Intangible assets, net of accumulated amortization | $557.6M | $595.2M | |
| Operating lease right-of-use assets, net | $171.6M | $161.0M | |
| Deferred income taxes, net | $0 | $5.3M | |
| Other assets | $39.7M | $39.1M | |
| Total assets | $6.4B | $5.9B | |
| Trade accounts payable | $1.2B | $923.9M | |
| Accrued expenses | $333.0M | $295.7M | |
| Current portion of obligations under operating leases | $42.9M | $38.9M | |
| Current portion of obligations under financing leases | $6.8M | $3.5M | |
| Current portion of long-term debt | $52.3M | $48.7M | |
| Total current liabilities | $1.8B | $1.4B | |
| Obligations under operating leases, net of current portion | $135.4M | $129.5M | |
| Obligations under financing leases, net of current portion | $14.5M | $6.5M | |
| Long-term debt, net of current portion | $2.5B | $2.6B | |
| Deferred income taxes, net | $6.2M | ||
| Long-term liabilities | $66.6M | $71.2M | |
| Total liabilities | $4.5B | $4.3B | |
| Redeemable noncontrolling interests | $11.2M | $3.7M | |
| Common stock, $0.01 par value, 1,500,000,000 shares authorized, 192,124,125 and 174,245,990 shares issued and outstanding at December 31, 2025 and 2024, respectively | $1.9M | $1.7M | |
| Preferred stock, $0.01 par value, 250,000,000 authorized; no shares issued and outstanding at December 31, 2025 and 2024 | $0 | ||
| Additional paid-in capital | $2.0B | $1.9B | |
| Accumulated deficit | -$74.6M | -$222.2M | |
| Accumulated other comprehensive (loss) income | -$6.7M | $1.4M | |
| Total shareholders' equity | $1.9B | $1.6B | |
| Noncontrolling interest | $74.0K | $0 | |
| Total equity | $1.9B | $1.6B | $585.4M |
| Total liabilities, redeemable noncontrolling interests, and equity | $6.4B | $5.9B | |
| Property and equipment, net of accumulated depreciation | $404.9M | $339.9M | |
| Common Stock, par value | $0.01 | $0.01 | |
| Common Stock, shares authorized | 1.5B shares | 1.5B shares | |
| Common Stock, Shares, Issued | 192.1M shares | 174.2M shares | |
| Common Stock, shares outstanding | 192.1M shares | 174.2M shares | |
| Preferred Stock , par value | $0.01 | $0.01 | |
| Preferred Stock, shares authorized | 250.0M shares | 250.0M shares | |
| Preferred Stock, shares issued | 0 shares | 0 shares | |
| Preferred Stock, shares outstanding | 0 shares | 0 shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | $189.1M | -$20.5M | -$156.8M |
| Depreciation and amortization | $164.3M | $204.5M | $202.3M |
| Impairment of long-lived assets | $12.6M | $10.2M | $10.6M |
| Change in fair value of contingent consideration, net | -$1.3M | $2.3M | |
| Payment of contingent consideration in excess of acquisition date fair value | -$6.2M | -$2.4M | |
| Provision for credit losses | $56.2M | $34.0M | $23.2M |
| Amortization of deferred debt issuance costs | $11.2M | $12.1M | $20.9M |
| Share-based compensation | $70.1M | $69.2M | $3.9M |
| Deferred income taxes, net | $14.8M | -$25.9M | -$52.6M |
| Loss on extinguishment of debt | $12.7M | ||
| Loss on disposition of fixed assets | $2.1M | $101.0K | $349.0K |
| Other | -$4.4M | -$2.5M | -$572.0K |
| Accounts receivable | -$131.3M | -$179.0M | -$127.2M |
| Prepaid expenses and other current assets | $30.7M | $7.6M | -$34.9M |
| Inventories | -$177.9M | -$236.5M | $28.7M |
| Trade accounts payable | $264.2M | $303.2M | $105.6M |
| Accrued expenses | $32.0M | -$144.6M | $193.6M |
| Other assets and liabilities | -$36.2M | -$20.7M | -$6.4M |
| Net cash provided by operating activities | $490.2M | $23.8M | $210.8M |
| Purchases of property and equipment | -$95.5M | -$80.9M | -$73.5M |
| Acquisitions of businesses, net of cash acquired | -$204.6M | -$59.8M | -$63.1M |
| Other | -$5.0M | $473.0K | $2.2M |
| Net cash used in investing activities | -$305.1M | -$140.2M | -$134.4M |
| Long-term debt borrowings | $2.6B | ||
| Long-term debt repayments | -$50.3M | -$3.4B | -$30.4M |
| Proceeds from issuance of common stock on initial public offering, net | $656.5M | ||
| Proceeds from issuance of tangible equity units, net | $389.0M | ||
| (Repayments) borrowings of the Revolving Credit Facility, net | -$63.3M | $12.6M | -$24.1M |
| Payment of debt issuance costs | -$47.0M | ||
| Repurchase of shares of common stock | -$43.2M | -$650.0K | -$650.0K |
| Proceeds from shares issued under share-based compensation plan | $25.3M | $1.5M | $598.0K |
| Payment of taxes related to net share settlement of equity awards | -$7.6M | -$1.2M | |
| Repurchase of stock options | -$10.0M | ||
| Payment of contingent consideration up to acquisition date fair value | -$200.0K | -$1.8M | -$1.5M |
| Purchase of redeemable noncontrolling interest | -$5.1M | -$2.3M | |
| Investment in noncontrolling interests | $735.0K | ||
| Payment of financing lease obligations | -$13.5M | -$11.6M | -$11.6M |
| Net cash (used in) provided by financing activities | -$157.9M | $164.6M | -$76.9M |
| Net increase (decrease) in cash and cash equivalents | $27.2M | $48.2M | -$557.0K |
| Interest, net | $183.5M | $211.4M | $303.5M |
| Income taxes, net of refunds | $27.0M | $25.0M | $37.5M |
| Notes issued and contingent liabilities assumed in connection with acquisitions | $22.3M | $7.5M | |
| Financing lease obligations (Note 13) | $20.3M | $13.1M | $11.6M |
| Repurchases of common stock in accounts payable | $650.0K | ||
| Purchases of property and equipment in accounts payable | $6.8M | $12.1M | $13.0M |
| Acquisition consideration in accounts payable | $42.2M | $2.5M | |
| Consideration for purchase of redeemable noncontrolling interest in accounts payable | $5.1M | ||
| Shares issued in connection with acquisitions | $31.1M |
Compare BrightSpring Health Services, Inc. with another company
Recent filings
- Sep 16, 20264
- Sep 14, 2026144
- Aug 6, 2026SCHEDULE 13G/A
- Jul 31, 20268-K
- Jul 31, 202610-Q
- Jul 31, 2026SCHEDULE 13G
- Jul 28, 20264
- Jul 27, 2026SCHEDULE 13G/A
- Jun 22, 20264
- Jun 12, 20268-K
- Jun 12, 20263
- Jun 12, 20264
- Jun 5, 2026424B7
- Jun 5, 20268-K
- Jun 5, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2Yahoo FinanceBTSG quote
- 3
- 4
- 5
- 6
- 7